Dementia and Geriatric Cognitive Disorders

Akarsu G.D.a· Çetin A.b

Author affiliations

aSchool of Health Services, Yozgat Bozok University, Yozgat, Turkey
bDepartment of Biochemistry and Clinical Biochemistry, Faculty of Medicine, Erciyes University, Kayseri, Turkey

Dement Geriatr Cogn Disord

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: February 16, 2022
Accepted: June 14, 2022
Published online: October 21, 2022

Number of Print Pages: 13
Number of Figures: 11
Number of Tables: 3

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Abstract

Introduction: In this study, it was aimed to investigate the effect of thymoquinone (TQ) on oxidative stress and apolipoprotein E (ApoE) in an experimental Alzheimer’s model created with AlCl3 and D-galactose in rats. Methods: Thirty-six Wistar Albino male rats saline group (Group 1), aluminum chloride (AlCl3) + D-galactose (D-Gal) group (Group 2), AlCl3 + D-Gal + TQ group (Group 3) were divided into 3 groups. The study was completed with 33 rats. Group 1 was given saline intraperitoneally (i.p) for 28 days. 2nd group; D-Gal at a dose of 60 mg/kg/day and AlCl3 at a dose of 40 mg/kg/day were given i.p. daily for 28 days. 3rd group; D-Gal at a dose of 60 mg/kg/day and AlCl3 at a dose of 40 mg/kg/day were given i.p. daily for 28 days. Group 3 rats were given 20 mg/kg/day TQ in corn oil by gavage for 14 days. Malonyl dialdehyde (MDA), superoxide dismutase (SOD), total antioxidant capacity (TAS), total oxidant capacity (TOS), glutathione peroxidase (GsH-Px), and ApoE levels were determined in the blood and brain tissues of rats in all three groups. One-way ANOVA test was used in the statistical analysis of the data. Results: Means of TAS, TOS, GSH-Px, SOD, MDA, and ApoE in blood and brain tissue of all three groups (excluding ApoE in brain tissue) were different from each other and this difference was statistically significant (p < 0.05). Conclusion: In this study, TQ, it was determined that all oxidative stress parameters examined had positively affected and decreased blood tissue ApoE levels. TQ can be used as an antioxidant and curative in Alzheimer’s disease.

© 2022 S. Karger AG, Basel

References Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Alzheimer’s disease drug development pipeline: 2019. Alzheimers Dement. 2019;5:272–93. Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer’s disease. Ther Adv Neurol Disord. 2013;6(1):19–33. Matsunaga S, Kishi T, Iwata N. Memantine monotherapy for Alzheimer’s disease: a systematic review and meta-analysis. PLoS One. 2015;10(4):e0123289. Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain. 2018;141(7):1917–33. Gülşen İ, Ak H, Çölçimen N, Alp HH, Akyol ME, Demir I, et al. Neuro protective effects of thymoquinone on the hippocampus in a rat model of traumatic brain injury. World Neurosurg. 2016;86:243–9. Poorgholam P, Yaghmaei P, Hajebrahimi Z. Thymoquinone recovers learning function in a rat model of Alzheimer’s disease. Avicenna J Phytomed. 2018;8(3):188. Li Z, Zhao G, Qian S, Yang Z, Chen X, Chen J, et al. Cerebrovascular protection of β-asarone in Alzheimer’s disease rats: a behavioral, cerebral blood flow, biochemical and genic study. J Ethnopharmacol. 2012;144(2):305–12. Kou X, Liu X, Chen X, Li J, Yang X, Fan J, et al. Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1/mTOR signal pathway. Oncotarget. 2016;7(46):74484. Abulfadl YS, El-Maraghy NN, Ahmed AE, Nofal S, Abdel-Mottaleb Y, Badary OA. Thymoquinone alleviates the experimentally induced Alzheimer’s disease inflammation by modulation of TLRs signaling. Hum Exp Toxicol. 2018;37(10):1092–104. Hughes RN. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav Rev. 2004;28(5):497–505. Momeni S, Segerström L, Roman E. Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats. Front Neurosci. 2015;9(424):424–36. Yan T, He B, Wan S, Xu M, Yang H, Xiao F, et al. Antidepressant-like effects and cognitive enhancement of Schisandra chinensis in chronic unpredictable mild stress mice and its related mechanism. Sci Rep. 2017;7(1):6903. Dalli T, Beker M, Terzioglu-Usak S, Akbas F, Elibol BV. Thymoquinone activates MAPK pathway in hippocampus of streptozotocin-treated rat model. Biomed Pharmacother. 2018;99:391–401. Alayunt Ö. Nigella Sativa yağı'nın metabolik sendrom oluşturulmuş sıçanlarda serum beyin kaynaklı nörotrofik faktör (bdnf), biyojenik aminler ve oksidatif stres üzerine etkileri, yüksek lisans tezi, fırat üniversitesi, sağlık bilimleri enstitüsü. Elazığ. 2015. Aksoy F, Dogan R, Ozturan O, Tugrul S, Veyseller B, Ozer OF, et al. An evaluation of the protective effects of thymoquinone on amikacin-induced ototoxicity in rats. Clin Exp Otorhinolaryngol. 2015;8(4):312–9. Bai T, Lian LH, Wu YL, Wan Y, Nan JX. Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells. Int Immunopharmacol. 2013;15(152):275–81. Mabrouk A, Bel Hadj Salah BI, Chaieb W, Ben Cheikh H. Protective effect of thymoquinone against lead-induced hepatic toxicity in rats. Environ Sci Pollut Res Int. 2016;23(12):12206–15. Awad AS, Abd Al Haleem EN, El-Bakly WM, Sherief MA. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(4):381–91. Mercan T. Doksorubisin ile kalp yetmezliği oluşturulan sıçanlarda timokinonun kardiyoprotektif etkilerinin araştırılması, doktora tezi, akdeniz üniversitesi. Antalya: Sağlık Bilimleri Enstitüsü; 2021. Cikman O, Taysi S, Gulsen MT, Demir E, Akan M, Diril H, et al. The radio-protective effects of caffeic acid phenethyl ester and thymoquinone in rats exposed to total head irradiation. Wien Klin Wochenschr. 2015;127(3):103–8. Aydin MS, Kocarslan A, Kocarslan S, Kucuk A, Eser İ, Sezen H, et al. Thymoquinone protects end organs from abdominal aorta ischemia/reperfusion injury in a rat model. Rev Bras Cir Cardiovasc. 2015;30(1):77–83. Türkeri ÖN. İskemiReperfüzyonla indüklenen rat over hasarı üzerine timokinonun biyokimyasal ve histopatolojik etkisi, doktora tezi, atatürk üniversitesi, sağlık bilimleri enstitüsü. Erzurum; 2019. Madkour DA, Ahmed MM, Orabi SH, Sayed SM, Korany RM, Khalifa HK. Nigellasativa oil protects against emamectin benzoate: Induced neurotoxicity in rats. Environ Toxicol. 2021;36(8):1521–35. Mohamadin AM, Sheikh B, Abd El-Aal AA, Elberry AA, Al-Abbasi FA. Protective effects of Nigella sativa oil on propoxur-induced toxicity and oxidative stress in rat brain regions. Pestic Biochem Phys. 2010;98(1):128–34. Hamdy NM, Taha R. Effects of Nigella sativa oil and thymoquinone on oxidative stress and neuropathy in streptozotocin-induced diabetic rats. Pharmacology. 2009;84:127–34. Alam MF, Khan G, Safhi MM, Alshahrani S, Siddiqui R, Sivagurunathan Moni S, et al. Thymoquinone ameliorates doxorubicin-induced cardiotoxicity in Swiss Albino mice by modulating oxidative damage and cellular inflammation. Cardiol Res Pract. 2018;2018:1–6. Amizadeh S, Rashtchizadeh N, Khabbazi A, Ghorbanihaghjo A, Ebrahimi A, Vatankhah AM, et al. Effect of Nigella sativa oil extracts on inflammatory and oxidative stress markers in Behcet’s disease: a randomized, double-blind, placebo-controlled clinical trial. Avicenna J Phytomed. 2020;10(2):181. Mohit M, Farrokhzad A, Faraji SN, Heidarzadeh-Esfahani N, Kafeshani M. Effect of Nigella sativa L. supplementation on inflammatory and oxidative stress indicators: a systematic review and meta-analysis of controlled clinical trials. Complement Therapies Med. 2020;54:102535. Demir E, Taysi S, Ulusal H, Kaplan DS, Cinar K, Tarakcioglu M. Nigella sativa oil and thymoquinone reduce oxidative stress in the brain tissue of rats exposed to total head irradiation. Int J Radiat Biol. 2020;96(2):228–35. Article / Publication Details

First-Page Preview

Received: February 16, 2022
Accepted: June 14, 2022
Published online: October 21, 2022

Number of Print Pages: 13
Number of Figures: 11
Number of Tables: 3

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.